Whether you are interested in a collaboration, career, investment opportunity or media inquiry, we’d love to hear from you. Please fill out the form below and we’ll get back to you shortly.
Lyvgen is a biopharmaceutical company focused on developing novel therapies for cancer. Lyvgen’s xLinkAb™ functional platform creates agonist antibodies (Abs) with tumor-localized immunostimulatory activities by balancing multiple functions of candidate Abs.